ES2063300T3 - Derivado de acido aminobencensulfonico. - Google Patents

Derivado de acido aminobencensulfonico.

Info

Publication number
ES2063300T3
ES2063300T3 ES90400795T ES90400795T ES2063300T3 ES 2063300 T3 ES2063300 T3 ES 2063300T3 ES 90400795 T ES90400795 T ES 90400795T ES 90400795 T ES90400795 T ES 90400795T ES 2063300 T3 ES2063300 T3 ES 2063300T3
Authority
ES
Spain
Prior art keywords
group
derivative
aminobencensulfonico
acid
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90400795T
Other languages
English (en)
Inventor
Hiromi Okushima
Akihiro Narimatsu
Makio Kobayashi
Naoya Satoh
Miyuki Morita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Kasei Corp
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp, Mitsubishi Chemical Industries Ltd filed Critical Mitsubishi Kasei Corp
Application granted granted Critical
Publication of ES2063300T3 publication Critical patent/ES2063300T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

HAY DESCUBIERTO UN DERIVADO DE ACIDO AMINOBENCENOSULFONICO DE LA FORMULA: EN DONDE R1 REPRESENTA HIDROGENO, UN GRUPO ALQUIL C1-C6, UN GRUPO CICLOALQUIL C3-C7, UN GRUPO ALQUIL HALOGENADO C1-C4, UN HALOGENO O UN GRUPO ARIL C6-C12; R2 REPRESENTA HIDROGENO, UN GRUPO ALQUIL C1-C6 O UN GUPO ARALQUIL C7-C12, QUE DEBE TENER AL MENOS UN SUSTITUYENTE SELECCIONADO DEL GRUPO CIANO, GRUPO NITRO, GRUPOS ALCOXI C1-C6, HALOGENOS, GRUPOS ALQUIL C1-C6 Y GRUPOS AMINO; Y N REPRESENTA UN ENTERO DE 1 A 4,O SU SAL ACEPTABLE FARMACEUTICAMENTE.
ES90400795T 1989-03-27 1990-03-22 Derivado de acido aminobencensulfonico. Expired - Lifetime ES2063300T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7468489 1989-03-27
JP2064811A JPH0686438B2 (ja) 1989-03-27 1990-03-15 アミノベンゼンスルホン酸誘導体

Publications (1)

Publication Number Publication Date
ES2063300T3 true ES2063300T3 (es) 1995-01-01

Family

ID=26405909

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90400795T Expired - Lifetime ES2063300T3 (es) 1989-03-27 1990-03-22 Derivado de acido aminobencensulfonico.

Country Status (7)

Country Link
EP (1) EP0390654B1 (es)
JP (1) JPH0686438B2 (es)
AT (1) ATE113940T1 (es)
CA (1) CA2013037C (es)
DE (1) DE69013959T2 (es)
DK (1) DK0390654T3 (es)
ES (1) ES2063300T3 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192731C (en) 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
US5965560A (en) * 1996-04-30 1999-10-12 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
CN1109677C (zh) * 1997-06-13 2003-05-28 三菱化学株式会社 氨基苯磺酸衍生物的单水合物及其制备方法
DE69941897D1 (de) * 1998-02-12 2010-02-25 Mitsubishi Chem Corp Arzneimittel für nicht-cardiogene diastolische dysfunktion
US6407113B1 (en) 1998-02-12 2002-06-18 Mitsubishi Chemical Corporation Medicament for treatment of diastolic dysfunction
AU2398001A (en) * 1999-12-21 2001-07-03 Mitsubishi Pharma Corporation Remedies and/or preventives for nervous system disorders
WO2002004433A2 (en) 2000-07-06 2002-01-17 Neurogen Corporation Melanin concentrating hormone receptor ligands
US20050124632A1 (en) * 2001-03-13 2005-06-09 Yoshimi Kitada Remedies and/or preventives for diabetic ischemic heart diseases
BR0209932A (pt) 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
EP1409080A1 (en) * 2001-07-25 2004-04-21 Mitsubishi Pharma Corporation Medicament inhibiting sodium/calcium exchange system
US20050004139A1 (en) * 2001-07-30 2005-01-06 Takeshi Inamori Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient
US20060167013A1 (en) * 2002-08-30 2006-07-27 Naoya Satou Inhibitors for excessive accumulation of sodium ion in cells
WO2004022545A1 (ja) * 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
EP1723955A4 (en) * 2004-03-05 2009-12-23 Mitsubishi Tanabe Pharma Corp MEDICAMENT FOR THE PREVENTION AND / OR TREATMENT OF ISCHEMIC CIRCULAR DISEASE
WO2005110982A2 (en) 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
EP2050741A4 (en) * 2006-07-21 2009-10-28 Mitsubishi Tanabe Pharma Corp CRYSTALLINE POLYMORPHISM OF 5-METHYL-2- (PIPERAZINE-1-YL) BENZOLSULPHONIC ACID
WO2008010567A1 (fr) * 2006-07-21 2008-01-24 Mitsubishi Tanabe Pharma Corporation Sel ou solvate d'acide 5-méthyl-2-(pipérazin-1-yl)benzènesulfonique
JPWO2008032814A1 (ja) * 2006-09-14 2010-01-28 田辺三菱製薬株式会社 含アスピリン医薬
WO2011134169A1 (en) 2010-04-30 2011-11-03 Beijing Institute Of Technology Wide angle and high resolution tiled head-mounted display device
WO2026004998A1 (ja) * 2024-06-28 2026-01-02 田辺三菱製薬株式会社 角化症用医薬組成物およびその用途
TW202610627A (zh) * 2024-06-28 2026-03-16 日商田邊三菱製藥股份有限公司 家族性良性慢性天疱瘡用醫藥組成物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1104514B (de) * 1955-06-29 1961-04-13 Parke Davis & Co Verfahren zur Herstellung von blutdrucksenkend wirkenden 1-Mercaptophenyl-4-piperazino-alkoholen
DE2040279A1 (de) * 1970-08-13 1972-02-17 Hoechst Ag Verfahren zur Herstellung basisch substituierter Benzolsulfonamide
DE2111811A1 (de) * 1971-03-12 1972-09-14 Hoechst Ag Basisch substituierte Benzolsulfonylformamidine und Verfahren zu ihrer Herstellung
DE3715763A1 (de) * 1987-05-12 1988-11-24 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
DE69013959D1 (de) 1994-12-15
DK0390654T3 (da) 1995-04-03
ATE113940T1 (de) 1994-11-15
EP0390654B1 (en) 1994-11-09
JPH0686438B2 (ja) 1994-11-02
CA2013037C (en) 1999-12-07
CA2013037A1 (en) 1990-09-27
JPH037263A (ja) 1991-01-14
DE69013959T2 (de) 1995-03-16
EP0390654A1 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
DE69013959D1 (de) Aminobenzolsulfonsäurederivate.
AU7503087A (en) Amide derivatives
AU8891091A (en) Preparation and use of n-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
PT918776E (pt) Sintese total de acilfulvenos antitumorais
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
MX9100227A (es) Derivados de cefalosporina y procedimiento para su preparacion.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
FI884088A0 (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
AU623500B2 (en) Carboxylimino benzothiazole derivatives
EP0785190A3 (es)
GR3036029T3 (en) Optically active thiazolidinone derivatives
AU610913B2 (en) 2'-deoxy-5-fluorouridine derivatives
ES2032214T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
ATE139767T1 (de) Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
MY134476A (en) Aromatic compounds, their production processes and their compositions for the control of insect pests

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 390654

Country of ref document: ES